Evaluating the Benefit of Home Support Provider Services for Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea: Protocol for an Ambispective International Real-World Study
JMIR Research Protocols · 2025
DOI: 10.2196/65840 ↗At a glance
Studienprotokoll in JMIR Research Protocols, 2025. Written by Sarah Alami and 14 co-authors. Institution: Air Liquide Santé International, Bagneux, France. Major MEDLINE topics: Sleep Apnea, Obstructive, Home Care Services, Continuous Positive Airway Pressure. Cited 1 times so far (Crossref); 63 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
Adherence and persistence to positive airway pressure (PAP) therapy are key factors for positive health outcomes. Home support providers participate in the home implementation and follow-up of PAP therapy for patients with obstructive sleep apnea (OSA). In Europe, home support provider service levels are country (or area) specific, resulting in differences in content and frequency of patient interactions. However, no robust evaluation of the impact of these differences on clinical and patient outcomes has been performed.
Objective
The AWAIR study aims to evaluate and compare the impact of different home support provider service levels on PAP adherence and persistence in 4 European countries.
Methods
This real-world, ambispective, cohort study—conducted in France, Belgium, Spain, and Portugal—will recruit adults with OSA who started PAP therapy between 2019 and 2023 and were followed by an Air Liquide Healthcare home support provider. Given the large number of eligible participants (around 150,000), the study will use a decentralized and digital approach. A patient video will present the study objectives and the participation process. A secure electronic solution will be used to manage patient information and consent, as well as to administer a web-based questionnaire. Retrospective data, collected during routine patient follow-up by home support providers, include the level of service and device data, notably PAP use. Prospective data collected using an electronic patient-reported outcome tool include health status, OSA-related factors, patient-reported outcomes including quality of life and symptoms, OSA and PAP literacy, patient-reported experience, and satisfaction with PAP therapy and service. Hierarchical models, adjusted for preidentified confounding factors, will be used to assess the net effect of home support provider services on PAP adherence and persistence while minimizing real-world study biases and considering the influence of country-level contextual factors. We hypothesize that higher levels of home support provider services will be positively associated with adherence and persistence to PAP therapy.
Results
As of December 2024, the study has received approval in France, Portugal, and 2 regions of Spain. The study began enrollment in France in October 2024. Results are expected in the second quarter of 2025.
Conclusions
The AWAIR study has a unique design, leveraging an unprecedented number of eligible participants, decentralized technologies, and a real-world comparative methodology across multiple countries. This approach will highlight intercountry differences in terms of patient characteristics, PAP adherence, and persistence, as well as patient-reported outcomes, patient-reported experiences, and satisfaction with the home service provider. By assessing the added value of home support provider services, the results will support best practices for patient management and for decision-making by payers and authorities. International Registered Report Identifier (IRRID) PRR1-10.2196/65840
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Air Liquide Santé International, Bagneux, France.
- VitalAire Spain, Madrid, Spain.
- Department of Respiratory and Sleep Medicine, Angers University Hospital, Angers, France.
- Thorax Department, Unidade Local de Saúde Santa Maria, Lisbon, Portugal.
- Faculty of Medicine of Lisbon, Instituto de Saúde Ambiental, Lisbon, Portugal.
- Sleep Unit and Respiratory Department, Hospital Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
ORCID profiles: Sarah Alami, Manuella Schaller, Sylvie Blais, Henry Taupin, Marta Hernández González, Frédéric Gagnadoux, Paula Pinto, Irene Cano-Pumarega, Lieven Bedert, Ben Braithwaite, Hervé Servy, Stéphane Ouary, Céline Fabre, Fabienne Bazin, Joëlle Texereau
Cite
APA
Alami, S., Schaller, M., Blais, S., Taupin, H., Hernández González, M., Gagnadoux, F., Pinto, P., Cano-Pumarega, I., Bedert, L., Braithwaite, B., Servy, H., Ouary, S., Fabre, C., Bazin, F., & Texereau, J. (2025). Evaluating the Benefit of Home Support Provider Services for Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea: Protocol for an Ambispective International Real-World Study. JMIR Research Protocols. https://doi.org/10.2196/65840
Vancouver
Alami S, Schaller M, Blais S, Taupin H, Hernández González M, Gagnadoux F, et al. Evaluating the Benefit of Home Support Provider Services for Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea: Protocol for an Ambispective International Real-World Study. JMIR Research Protocols. 2025. doi:10.2196/65840
BibTeX
@article{Alami2025,
author = {Alami, Sarah and Schaller, Manuella and Blais, Sylvie and Taupin, Henry and Hernández González, Marta and Gagnadoux, Frédéric and Pinto, Paula and Cano-Pumarega, Irene and Bedert, Lieven and Braithwaite, Ben and Servy, Hervé and Ouary, Stéphane and Fabre, Céline and Bazin, Fabienne and Texereau, Joëlle},
title = {Evaluating the Benefit of Home Support Provider Services for Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea: Protocol for an Ambispective International Real-World Study},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/65840}
}
EUVIMED